Table 2.
Bivariate correlations of hs-Troponin and NP with patients’ characteristics and laboratory results
| Variable | Troponin (Log10) | NP (Log10 (factor × URN)) | ||
|---|---|---|---|---|
| R | P | R | P | |
| Age | 0.484 | < 0.001 | 0.696 | < 0.001 |
| Sex (male) | 0.012 | 0.907 | − 0.180 | 0.106 |
| Previous CVD | 0.332 | 0.001 | 0.489 | < 0.001 |
| ACE inhibitor/ARB therapy | 0.021 | 0.833 | 0.156 | 0.162 |
| Creatinine (mg/dl) | 0.288 | 0.003 | 0.244 | 0.027 |
| Hb (g/dl) | − 0.213 | 0.031 | − 0.412 | < 0.001 |
| CRP (Log10) | 0.396 | < 0.001 | 0.293 | 0.008 |
| D-dimer (Log10) | 0.366 | < 0.001 | 0.358 | 0.001 |
| Hs-Troponin (Log10) | NA | NA | 0.730 | < 0.001 |
| NP factor x URN (log10) | 0.730 | < 0.001 | NA | NA |
| pH | 0.063 | 0.535 | − 0.040 | 0.728 |
| pO2 | 0.030 | 0.766 | − 0.086 | 0.443 |
| pCO2 | − 0.059 | 0.560 | − 0.049 | 0.667 |
| PaO2/FIO2 | − 0.411 | < 0.001 | − 0.347 | 0.001 |
Pearson’s and Spearman (rho) coefficient, as appropriate for the type of the data; p value < 0.05 was considered significant. Bold values indicates p < 0.05
NP Natriuretic peptide, CVD cardiovascular disease, ACE angiotensin-converting enzyme, ARB angiotensin receptor blocker, Hb hemoglobin, CRP C-reactive protein, NA not applicable